Navigation Links
New Queen's spin-in company to revolutionize cancer detection

The development of novel medical imaging techniques to revolutionise cancer detection and treatment will be the result of a new partnership announced today between Queen's University Belfast and Cirdan Imaging Ltd.

The research will focus on developing new imaging equipment using X-rays and near Infrared (NIR) Fluorescence to assist clinicians in the detection, diagnosis and treatment of cancer.

Complete surgical removal of a tumour is vital for the patient, and one of the most important prognostic factors for survival. The new devices will be used in diagnostic procedures, as well as cancer surgery, to better discriminate between healthy and malignant tissue.

Cirdan Imaging's first new device will be an imaging tool developed to assist Radiologists to take a biopsy from a suspect lesion to help diagnose breast cancer. This product is planned to be launched within the next 12 months.

Queen's University have taken an equity shareholding in Cirdan Imaging Ltd through its venture spin-out company QUBIS Ltd, representing their first ever company spin-in.

Dr. Hugh Cormican is CEO of Cirdan Imaging. His previous collaboration with QUBIS led to the creation of Andor Technology, the fastest growing company manufacturing high performance digital cameras in the world today, employing some 260 people in 16 offices worldwide.

Speaking about the new partnership, Dr Cormican said: "I am delighted to be working with QUBIS and Queen's University again, and I look forward to the collaborative efforts in developing new cancer imaging techniques. We know that speed of detection and treatment of cancer is critical to patient outcomes and we hope that through this new faster, more efficient technology, patient outcomes and survival will be improved.

"Queen's University is one of the world's leading research centres for cancer research, and with our collaboration we can help bring the benefits of that research to impact on patient's lives in considerably shorter timescales than occur elsewhere in the world. In business terms we anticipate that there is also the potential to be the next IPO (AIM stock exchange listing) for Northern Ireland in five years time."

QUBIS CEO, Frank Bryan, said: "QUBIS is delighted to be involved in supporting this research initiative which will help develop safer, more cost effective, user friendly and compact diagnostic tools for early, more accurate diagnosis of cancer globally. Research into cancer has predominately been on getting an improved understanding of the disease, or on new therapeutics. Cirdan Imaging is focused on developing more accurate detection tools for the clinicians to better diagnose and treat the cancer, an area which has lagged behind. The team in Cirdan have an impressive track record in imaging technology and we are excited to be involved in this project."

Contact: Claire O'Callaghan
Queen's University Belfast

Related medicine news :

1. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
2. San Francisco Bath Salt Company Clears Air About Bath Salt Confusion – Zombies Beware!
3. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
4. Through The Use Of Twitter, EverSmoke, A Popular Electronic Cigarettes Company, Is Encouraging Fans to Finish the Hashtag #iPlanToBe With What They Plan to Be
5. SingleSource Background Screening Company Calls On Adults To Take Proactive Approach To Stop Child Sexual Abuse
6. Polar RCX5 Tour de France Available At The Heart Rate Watch Company
7. The Biochar Company Partners with Hawaii Biochar Products
8. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
9. Study Suggests Vaccine May Help Kids With Brain Cancer
10. New Stool Test Might Aid in Early Detection of Colon Cancer
11. Study reveals how cancer drug causes diabetic-like state
Post Your Comments:
(Date:11/29/2015)... St. Petersburg, FL (PRWEB) , ... November 30, 2015 , ... The Cyber Monday deal ... webstore. , It is the right time to get gifts for the skin care lover ... bow on top filled with serums . This year, the 3 serums are staples: Collagen, ...
(Date:11/29/2015)... PITTSBURGH, PA (PRWEB) , ... November 29, 2015 , ... ... assistance with kneeling or provide ready access to exercise weights. Fortunately, an inventor from ... prototype for THE TOMMY WALKER to enhance the benefits of a standard walker to ...
(Date:11/29/2015)... ... November 29, 2015 , ... Effective immediately, every single IguanaMed scrub ... on Black Friday Target is offering a “Buy One Scrub Set, Get the 2nd ... opportunity to purchase IguanaMed at a discounted price. , IguanaMed’s mission is ...
(Date:11/28/2015)... ... 28, 2015 , ... Safe storage for contraceptive devices may not always be ... New Jersey and the other from Bradley Beach, New Jersey, there is an easy ... of having to replace NuvaRings more often than necessary. As such, it affords peace ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Pixel Film Studios ... media panels to choose from, the possibilities are endless. Users have full control over ... the ProPanel: Pulse masking effects, users are sure to get heads to turn. , ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... 29, 2015 CIVCO Medical Solutions will ... the Radiological Society of North America ... November 29 – December 4, 2015. ... offer customers unrivaled versatility, enhanced user experience and ... --> ...
(Date:11/27/2015)... 2015  Lannett Company, Inc. (NYSE: LCI ... acquisition of Kremers Urban Pharmaceuticals Inc. (KU), the ... company UCB S.A. (Euronext: UCB). ... KU from UCB for total consideration of approximately ... customary working capital adjustment, a deduction of certain ...
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
Breaking Medicine Technology: